Core Insights - TELUS Corporation is recognized among the 15 Extreme Dividend Stocks to Buy According to Hedge Funds [1] - Barclays has lowered its price target for TELUS to $14 from $15 while maintaining an Equal Weight rating following the company's Q3 results [2] Financial Performance - In Q3 2025, TELUS reported revenue of C$5.11 billion, a modest increase of 0.2% year-over-year, but fell short of analysts' expectations by C$90 million [3] - The company added 288,000 Mobile and Fixed customers, driven by strong demand for high-value connectivity services and the expansion of TELUS PureFibre [3] - TELUS achieved an 8% growth in consolidated free cash flow, which supported a quarterly dividend increase to C$0.4184, marking the 22nd consecutive year of dividend growth [4] Business Expansion - TELUS Health experienced 18% growth in operating revenue and 24% growth in adjusted EBITDA, extending coverage to over 160 million lives globally [5] - The integration of LifeWorks contributed $417 million in combined annualized synergies, including $329 million from cost efficiencies and $88 million from cross-selling, keeping the company on track to meet its $427 million synergy target by the end of 2025 [5]